Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment
Open Access
- 1 November 2013
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 287
Abstract
We aimed to evaluate the safety and efficacy of TS-1 adjuvant chemotherapy in Taiwanese patients with gastric cancer.Keywords
This publication has 39 references indexed in Scilit:
- Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancerOncology Letters, 2012
- Chemotherapy for advanced gastric cancer2010
- Patient adherence and persistence with oral anticancer treatmentCA: A Cancer Journal for Clinicians, 2009
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate DataJournal of Clinical Oncology, 2006
- Phase I Pharmacokinetic Study of S-1 Plus Cisplatin in Patients With Advanced Gastric CarcinomaJournal of Clinical Oncology, 2005
- Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced MalignanciesClinical Cancer Research, 2004
- Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancerGastric Cancer, 2004
- Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206–1Journal of Clinical Oncology, 2003
- Mitomycin C as an Adjuvant in Resected Gastric CancerAnnals of Surgery, 1983